Tower Research Capital LLC (TRC) - NRX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of NRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,387
-82.3%
9,181
-67.1%
0.00%
Q2 2023$13,521
+135110.0%
27,936
+88.2%
0.00%
Q1 2023$10
+42.9%
14,842
+143.2%
0.00%
Q4 2022$7
-99.9%
6,102
-52.8%
0.00%
Q3 2022$10,000
+400.0%
12,936
+219.2%
0.00%
Q2 2022$2,000
-84.6%
4,053
-21.1%
0.00%
Q1 2022$13,000
+1200.0%
5,134
+2244.3%
0.00%
Q4 2021$1,000
-90.0%
219
-78.7%
0.00%
Q3 2021$10,000
+900.0%
1,026
+683.2%
0.00%
Q2 2021$1,0001310.00%
Other shareholders
NRX PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 325,000$84,5000.06%
Texas Capital Bank Wealth Management Services Inc 63,290$16,4550.00%
XTX Topco Ltd 11,809$3,0700.00%
United Asset Strategies, Inc. 18,300$4,7580.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 160,700$41,7820.00%
UBS Group AG 1,210$3150.00%
NewEdge Advisors, LLC 7,125$1,8530.00%
Lido Advisors, LLC 13,000$3,3800.00%
OSAIC HOLDINGS, INC. 11,125$2,8910.00%
WELLS FARGO & COMPANY/MN 5,379$1,3990.00%
View complete list of NRX PHARMACEUTICALS INC shareholders